If approved, this would be the first FDA approval for a weight loss drug since 1999. Although the FDA does not have to follow the committee’s recommendation, it usually does. The drug was rejected in 2010 per concerns about side effects such as possible heart problems and birth defects.
More Articles on Gastroenterology:
Starting From Scratch: Top 5 Tips on ASC Development From Manhattan Endoscopy Center
FDA Approves invendo medical’s Single-Use Colonoscope
Mayo Clinic Research Shows Virtual Colonoscopies Suitable for People Over 65
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
